Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/14/2025

Congenital Conditions Causing Potassium Shifts

Introduction to Congenital Conditions

  • Bartter syndrome and Gitelman syndrome are the primary congenital conditions that cause shifts in potassium levels, both presenting with hypokalemia due to renal potassium wasting from genetic defects in tubular ion transporters, as noted by the Kidney International guidelines 1, 2

Bartter Syndrome

  • The Kidney International guidelines state that Bartter syndrome is a group of congenital tubulopathies caused by mutations affecting the thick ascending limb of the loop of Henle, leading to severe renal potassium loss 1
  • Type 1 Bartter syndrome (SLC12A1 gene) is characterized by a defective Na+-K+-2Cl- cotransporter (NKCC2), presenting prenatally with severe polyhydramnios and severe hypokalemic metabolic alkalosis, according to the Kidney International guidelines 1
  • Type 2 Bartter syndrome (KCNJ1 gene) is characterized by a defective ROMK potassium channel, also presenting prenatally with severe polyhydramnios, as noted by the Kidney International guidelines 1
  • Type 3 Bartter syndrome (CLCNKB gene) presents between 0-5 years with polyuria, hypochloremia, and hypokalemia, as stated by the Kidney International guidelines 1
  • Type 4a and 4b Bartter syndrome (BSND gene) present prenatally with very severe polyhydramnios, deafness, and risk for chronic kidney disease, according to the Kidney International guidelines 1
  • Type 5 Bartter syndrome (MAGED2 gene) presents with transient disease, with pregnancies complicated by polyhydramnios, as noted by the Kidney International guidelines 1

Gitelman Syndrome

  • The Praxis Medical Insights guidelines state that Gitelman syndrome (SLC12A3 mutations) is distinguished from Bartter syndrome by later age of presentation (typically adolescence or adulthood, usually after age 6), hypocalciuria rather than hypercalciuria, and milder symptoms 2
  • The diagnostic triad of Gitelman syndrome consists of hypokalemia, hypomagnesemia, and hypocalciuria, with hypocalciuria being the critical distinguishing feature from Bartter syndrome, as noted by the Praxis Medical Insights guidelines 2
  • Fractional excretion of chloride >0.5% indicates renal salt wasting in both Bartter and Gitelman syndromes, according to the Kidney International and Praxis Medical Insights guidelines 1, 2

Hypokalemic Periodic Paralysis

  • Serum potassium drops due to intracellular sequestration, not increased excretion, in hypokalemic periodic paralysis, as stated by the American Journal of Kidney Diseases guidelines 3

Key Diagnostic Distinctions

  • Polyhydramnios is virtually always caused by Bartter syndrome when due to excessive fetal polyuria, with no reports of other inherited tubular disorders causing severe polyhydramnios, according to the Kidney International guidelines 1
  • Urinary chloride excretion (fractional chloride excretion >0.5%) distinguishes renal from extrarenal potassium losses, as noted by the Kidney International and Praxis Medical Insights guidelines 1, 2
  • Age at presentation is critical: prenatal/early infancy suggests Bartter syndrome, while adolescence/adulthood suggests Gitelman syndrome, according to the Kidney International and Praxis Medical Insights guidelines 1, 2
  • Urinary calcium helps differentiate: high in Bartter syndrome, low in Gitelman syndrome, as stated by the Kidney International and Praxis Medical Insights guidelines 1, 2

Clinical Pitfalls

  • Avoid diuretic testing (loop diuretics or thiazides) in suspected cases, as these tests are obsolete and carry potential risk of severe volume depletion, especially in infancy, according to the Kidney International guidelines 1
  • Genetic testing has surpassed functional testing for diagnosis, as noted by the Kidney International guidelines 1
  • Exclude diuretic abuse and laxative use before pursuing genetic diagnoses, as stated by the Kidney International guidelines 1